Screening assessment - 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)- (Doxorubicin) / [co-published...: En14-212/2015E-PDF
Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.700315&sl=0
| Department/Agency |
|
|---|---|
| Title | Screening assessment - 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)- (Doxorubicin) / [co-published with] Health Canada. |
| Publication type | Monograph |
| Language | [English] |
| Other language editions | [French] |
| Format | Digital text |
| Electronic document | |
| Note(s) |
|
| Publishing information |
|
| Description | 54p.figs., references, tables |
| ISBN | 978-1-100-25659-7 |
| Catalogue number |
|
| Subject terms |
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.Page details
- Date modified: